Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

Factors Associated with Subsequent Cancers in Patients with Moderate or Severe Chronic Graft-Versus-Host Disease after Transplant for Hematologic Malignancy

Dana Schaar, Filip Pirsl, Seth M. Steinberg, PhD, Laura Parsons-Wandell, Michael Emanuel, Shaneil Flucker, Jeannette Nashed, Claire Ruben, Lauren M. Curtis, MD, Edward W Cowen, MD, Jacqueline Mays, PhD DDS, Pashna N. Munshi, MD, Annie Im, MD, Ann Berger, MD, Galen O Joe, MD, Manuel B Datiles, III, MD, Steven Z. Pavletic, MD MS

Blood (2019) 134 (Supplement_1): 4558.

https://doi.org/10.1182/blood-2019-124020

Published: 2019

Journal Articles

A Case Report of the Benefit of Cannabidiol (Cannabidiol (CBD)-Predominant Medical Cannabis Preparation) in the Management of Refractory Skin Graft Vs Host Disease (GVHD)

Tsiporah B. Shore, MD, Jessy B. Ryan, ANP, Michael B. Samuel, MD

Blood (2019) 134 (Supplement_1): 5687.

https://doi.org/10.1182/blood-2019-122715

Published: 2019

Journal Articles

A Population-Based Study of Race & UV Exposure on Incidence & Survival in Mycosis Fungoides

Christin Destefano, MD, Aarthi Shenoy, MD

Blood (2017) 130 (Supplement 1): 2801.

https://doi.org/10.1182/blood.V130.Suppl_1.2801.2801

Published: 2017

Journal Articles

How I treat mycosis fungoides and Sézary syndrome

Sean Whittaker, Richard Hoppe, H. Miles Prince

Blood (2016) 127 (25): 3142–3153.

https://doi.org/10.1182/blood-2015-12-611830

Published: 2016

Journal Articles

A Novel DNA Repair Chip Assay Allows Rapid Identification of DNA Repair Abnormalities Induced By BCR-ABL

Ali G Turhan, MD PhD, Fanny Sarrazy, Marie Laure Bonnet, Angelina Bertrand, Marie Claude Meunier, Djamel Aggoune, Jean-Claude Chomel, PharmD, PhD, Olivier Feraud, Sylvain Caillat, Annelise Bennaceur-Griscelli, MD PhD, Sylvie Sauvaigo, PhD

Blood (2014) 124 (21): 4536.

https://doi.org/10.1182/blood.V124.21.4536.4536

Published: 2014

Journal Articles

Only Dendritic Cells, but Not Lymphocytes, Acquired Tolerogenicity by PUVA-Treatment by Upregulation of Indoleamine 2,3-Dioxygenase (IDO)

Hideaki Maeba, MD, Rie Kuroda, MD, Yo Niida, MD, PhD, Shintaro Mase, MD, Raita Araki, MD, Toshihiro Fujiki, MD, Akihiro Yachie, MD, PhD, Shoichi Koizumi, MD, PhD, Ryosei Nishimura, MD, PhD

Blood (2011) 118 (21): 2176.

https://doi.org/10.1182/blood.V118.21.2176.2176

Published: 2011

Journal Articles

Correction of the Fanconi Anemia Phenotype at the Cellular Level by S Phase Delay: Implications for Etiopathogenesis and Treatment

W. Clark Lambert, MD, PhD, Santiago Centurion, MD, Monique Brown

Blood (2010) 116 (21): 879.

https://doi.org/10.1182/blood.V116.21.879.879

Published: 2010

Journal Articles

Treatment of Sezary Syndrome with Combined Therapy

Giorgio Corinaldesi, MD, PhD

Blood (2010) 116 (21): 4928.

https://doi.org/10.1182/blood.V116.21.4928.4928

Published: 2010

Journal Articles

Low Dose Bexarotene and Ultraviolet A Photochemotherapy (PUVA) In a Prospective Phase II Clinical Study for Refractory and/or Resistant Cutaneous T Cell Lymphomas (CTCL)

Serena Rupoli, MD, Nicola Pimpinelli, MD, Gaia Goteri, MD, Lucia Canafoglia, MD, Paola Picardi, Giuliano Brandozzi, MD, Stefano Pulini, Irene Federici, PhD, Anna Rita Scortechini, md, Simona Tomassetti, MD, Lisa Albani, MD, Lidia Da Lio, MD, Mirella Giangiacomi, Pietro Leoni, MD

Blood (2010) 116 (21): 3953.

https://doi.org/10.1182/blood.V116.21.3953.3953

Published: 2010

Journal Articles

Potent Strategy for Treatmet of Gvhd and Autoimmune-Diseased by Infusion of Donor-Typed or Even Third-Party Tolerogenic Dendritic Cells by Psoralen Plus UVA Treatment

Hideaki Maeba, MD, Ryosei Nishimura, MD, PhD, Rie Kuroda, MD, Raita Araki, MD, Shintaro Mase, MD, Yasuhiro Ikawa, MD, PhD, Akihiro Yachie, MD, PhD, Shoichi Koizumi, MD, PhD

Blood (2010) 116 (21): 2777.

https://doi.org/10.1182/blood.V116.21.2777.2777

Published: 2010

Journal Articles

Improved Engraftment without Graft-Versus-Host Disease After MHC-Mismatched Cord Blood Transplantation with Photochemically Treated Donor Lymphocytes.

Bindu Kanathezhath, MD, Myra Mizokami, MD, PhD, Lynne Neumayr, M.D., Hua Guo, MD, Mark C. Walters, MD, Frans A. Kuypers, PhD

Blood (2009) 114 (22): 2425.

https://doi.org/10.1182/blood.V114.22.2425.2425

Published: 2009

Journal Articles

Long-Term Complete Responses to Combination Therapies in Sézary Patients.

Seema Daulat, MD, Rakhshandra Talpur, Chitra Hosing, Madeleine Duvic, MD

Blood (2009) 114 (22): 3369.

https://doi.org/10.1182/blood.V114.22.3369.3369

Published: 2009

Journal Articles

Strong Inhibition of Alloreaction by Newly Generated Tolerogenic Dendritic Cells by Psoralen Plus UVA Treatment.

Hideaki Maeba, MD, Ryosei Nishimura, MD, PhD, Rie Kuroda, MD, Raita Araki, MD, Shintaro Mase, MD, Yasuhiro Ikawa, MD, Akihiro Yachie, MD, PhD, Shoichi Koizumi, MD, PhD

Blood (2009) 114 (22): 3686.

https://doi.org/10.1182/blood.V114.22.3686.3686

Published: 2009

Journal Articles

The DNA Synthesis Inhibitor, Hydroxyurea, as a Potential Novel Therapeutic Approach for Fanconi Anemia: Further Studies in Complementation Group D1.

W. Clark Lambert, MD, PhD, Monique M Brown, PhD

Blood (2009) 114 (22): 4214.

https://doi.org/10.1182/blood.V114.22.4214.4214

Published: 2009

Journal Articles

Fox-2A Modulates Protein 4.1R Exon 16 5' Splice Site Activation.

Shu-Ching Huang, Guang Yang, PhD, Jennie Park, Alexander Ou, Edward J. Benz, Jr., MD

Blood (2009) 114 (22): 778.

https://doi.org/10.1182/blood.V114.22.778.778

Published: 2009

Journal Articles

How I treat mycosis fungoides and Sézary syndrome

H. Miles Prince, Sean Whittaker, Richard T. Hoppe

Blood (2009) 114 (20): 4337–4353.

https://doi.org/10.1182/blood-2009-07-202895

Published: 2009

Journal Articles

A Potential Novel Therapeutic Approach for Fanconi Anemia

W. Clark Lambert, MD, PhD, Monique M Brown, PhD

Blood (2008) 112 (11): 1040.

https://doi.org/10.1182/blood.V112.11.1040.1040

Published: 2008

Journal Articles

Successful Full-Term Live Birth in an Allogeneic Stem Cell Transplant Patient with Active Extensive Chronic Graft-Versus-Host Disease.

Heather Shah, MD, Donna Salzman, M.D., Khaleel Ashraf, M.D., William Vaughan, M.D.

Blood (2007) 110 (11): 5016.

https://doi.org/10.1182/blood.V110.11.5016.5016

Published: 2007

Journal Articles

The mitochondrial effects of novel apoptogenic molecules generated by psoralen photolysis as a crucial mechanism in PUVA therapy

Sergio Caffieri, Fabio Di Lisa, Federico Bolesani, Monica Facco, Gianpietro Semenzato, Francesco Dall'Acqua, Marcella Canton

Blood (2007) 109 (11): 4988–4994.

https://doi.org/10.1182/blood-2006-08-037192

Published: 2007

Journal Articles

The Pathogen Inactivation of Platelets: Studies of the Possible Mechanisms of the Platelet Dysfunction Seen Following Photochemical Treatment.

Adam D. Pyke, BA, MSc, Morris A. Blajchman, MD, FRCP(C)

Blood (2006) 108 (11): 581.

https://doi.org/10.1182/blood.V108.11.581.581

Published: 2006

NARROW

Factors Associated with Subsequent Cancers in Patients with Moderate or Severe Chronic Graft-Versus-Host Disease after Transplant for Hematologic Malignancy

A Case Report of the Benefit of Cannabidiol (Cannabidiol (CBD)-Predominant Medical Cannabis Preparation) in the Management of Refractory Skin Graft Vs Host Disease (GVHD)

A Population-Based Study of Race & UV Exposure on Incidence & Survival in Mycosis Fungoides

How I treat mycosis fungoides and Sézary syndrome

A Novel DNA Repair Chip Assay Allows Rapid Identification of DNA Repair Abnormalities Induced By BCR-ABL

Only Dendritic Cells, but Not Lymphocytes, Acquired Tolerogenicity by PUVA-Treatment by Upregulation of Indoleamine 2,3-Dioxygenase (IDO)

Correction of the Fanconi Anemia Phenotype at the Cellular Level by S Phase Delay: Implications for Etiopathogenesis and Treatment

Treatment of Sezary Syndrome with Combined Therapy

Low Dose Bexarotene and Ultraviolet A Photochemotherapy (PUVA) In a Prospective Phase II Clinical Study for Refractory and/or Resistant Cutaneous T Cell Lymphomas (CTCL)

Potent Strategy for Treatmet of Gvhd and Autoimmune-Diseased by Infusion of Donor-Typed or Even Third-Party Tolerogenic Dendritic Cells by Psoralen Plus UVA Treatment

Improved Engraftment without Graft-Versus-Host Disease After MHC-Mismatched Cord Blood Transplantation with Photochemically Treated Donor Lymphocytes.

Long-Term Complete Responses to Combination Therapies in Sézary Patients.

Strong Inhibition of Alloreaction by Newly Generated Tolerogenic Dendritic Cells by Psoralen Plus UVA Treatment.

The DNA Synthesis Inhibitor, Hydroxyurea, as a Potential Novel Therapeutic Approach for Fanconi Anemia: Further Studies in Complementation Group D1.

Fox-2A Modulates Protein 4.1R Exon 16 5' Splice Site Activation.

How I treat mycosis fungoides and Sézary syndrome

A Potential Novel Therapeutic Approach for Fanconi Anemia

Successful Full-Term Live Birth in an Allogeneic Stem Cell Transplant Patient with Active Extensive Chronic Graft-Versus-Host Disease.

The mitochondrial effects of novel apoptogenic molecules generated by psoralen photolysis as a crucial mechanism in PUVA therapy

The Pathogen Inactivation of Platelets: Studies of the Possible Mechanisms of the Platelet Dysfunction Seen Following Photochemical Treatment.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only